UltraSight and EchoNous Join Forces to Enhance Accessibility of Cardiac Ultrasound for Patients
Saturday, June 24, 2023
UltraSight, a pioneering digital health company leveraging artificial intelligence (AI) to revolutionize cardiac imaging, has joined forces with EchoNous, an innovator in point-of-care ultrasound technology. Their collaboration aims to broaden the availability of cardiac ultrasound by empowering more healthcare professionals to perform the procedure, ultimately increasing patient access to essential cardiac care. The partnership was recently announced at ASE 2023, a prominent event uniting echo professionals.
By integrating UltraSight's real-time AI guidance software with EchoNous' handheld ultrasound device, KOSMOS, the companies strive to enable healthcare professionals across diverse care settings to conduct echocardiographic examinations, regardless of prior sonography training. The combined capabilities of these cutting-edge technologies seek to facilitate convenient chronic cardiac patient monitoring in closer proximity to patients. UltraSight's FDA-submitted study, forming the basis for their software, has demonstrated that even users without extensive experience can successfully capture high-quality diagnostic cardiac ultrasound images with the assistance of real-time AI guidance.
Through this partnership, the focus is on equipping remote clinicians with the tools necessary for making life-saving diagnoses, facilitating cardiac monitoring, and potentially improving cardiac care for patients in rural areas. By enabling the acquisition of diagnostic-quality cardiac images at the point of care, the images can be remotely interpreted, offering enhanced accessibility to optimized cardiac care and cost-effective heart monitoring opportunities. The UltraSight real-time AI guidance software is currently undergoing FDA 510(k) review, indicating its potential to significantly impact the field of cardiac ultrasound.